[Summary] 多能干细胞药物的高新技术企业
意胜生物(EssentiaBioSciences)成立于2021年底,是一家专注于利用多能干细胞诱导分化胰岛组织的创新型细胞药研发公司。目标是通过多能干细胞在体外分化再生健康的胰岛组织,从源头治愈胰岛素依赖型糖尿病。该公司已经开发多条胰岛药物相关管线,其中进展*快的项目是多能干细胞分化胰岛细胞药物(ESN5800),已经完成了研发和生产的技术路线验证,正式进入产业化阶段。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows